Table of contents
Volume 82, Issue 12
Published online 23 May 2000 (1897-2036)
Reviews |
Regular Articles |
Letters to the Editor |
Author Index to Volume 82 |
Keyword Index to Volume 82
Editorial
Dose-dense chemotherapy for breast cancer: the story so far FREE
C Hudis
Br J Cancer 82: 1897-1899; doi:10.1054/bjoc.2000.1198
Reviews
Immune selection in neoplasia: towards a microevolutionary model of cancer development FREE
S J Pettit, K Seymour, E O'Flaherty and J A Kirby
Br J Cancer 82: 1900-1906; doi:10.1054/bjoc.2000.1206
Vinorelbine – a clinical review FREE
R K Gregory and I E Smith
Br J Cancer 82: 1907-1913; doi:10.1054/bjoc.2000.1203
Regular Articles
Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer FREE
R I Lalisang, E E Voest, J A Wils, J W Nortier, F L Erdkamp, H F Hillen, J Wals, H C Schouten and G H Blijham
Br J Cancer 82: 1914-1919; doi:10.1054/bjoc.2000.1202
Feasibility of a dose-intensive CMF regimen with granulocyte colony-stimulating factor as adjuvant therapy in premenopausal patients with node-positive breast cancer FREE
A M E Bos, H de Graaf, E G E de Vries, H Piersma and P H B Willemse
Br J Cancer 82: 1920-1924; doi:10.1054/bjoc.2000.1242
A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma FREE
M M Eatock, D A Anthony, M El-Abassi, P Wilson, J Paul, M Smith, M Soukop and T R J Evans
Br J Cancer 82: 1925-1931; doi:10.1054/bjoc.2000.1165
P53 germline mutations in childhood cancers and cancer risk for carrier individuals FREE
A Chompret, L Brugières, M Ronsin, M Gardes, F Dessarps-Freichey, A Abel, D Hua, L Ligot, M-G Dondon, B Bressac-de Paillerets, T Frébourg, J Lemerle, C Bonaïti-Pellié and J Feunteun
Br J Cancer 82: 1932-1937; doi:10.1054/bjoc.2000.1167
ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes FREE
D Delia, S Mizutani, S Panigone, E Tagliabue, E Fontanella, M Asada, T Yamada, Y Taya, S Prudente, S Saviozzi, L Frati, M A Pierotti and L Chessa
Br J Cancer 82: 1938-1945; doi:10.1054/bjoc.2000.1168
Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues FREE
J T-C Chang, C-T Liao, S-M Jung, T-C V Wang, L-C See and A-J Cheng
Br J Cancer 82: 1946-1951; doi:10.1054/bjoc.2000.1194
The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer FREE
A M Cook, R A Huddart, G Jay, A Norman, D P Dearnaley and A Horwich
Br J Cancer 82: 1952-1957; doi:10.1054/bjoc.2000.1147
Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors FREE
J Simony-Lafontaine, M Esslimani, E Bribes, S Gourgou, N Lequeux, R Lavail, J Grenier, A Kramar and P Casellas
Br J Cancer 82: 1958-1966; doi:10.1054/bjoc.2000.1162
Tissue factor, osteopontin, 
v
3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression FREE
S Takano, K Tsuboi, Y Tomono, Y Mitsui and T Nose
Br J Cancer 82: 1967-1973; doi:10.1054/bjoc.2000.1150
Expression of transcription factor AP-2 predicts survival in epithelial ovarian cancer FREE
M A Anttila, J K Kellokoski, K I Moisio, P J Mitchell, S Saarikoski, K Syrjänen and V-M Kosma
Br J Cancer 82: 1974-1983; doi:10.1054/bjoc.2000.1146
Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent FREE
L H Patterson, S R McKeown, K Ruparelia, J A Double, M C Bibby, S Cole and I J Stratford
Br J Cancer 82: 1984-1990; doi:10.1054/bjoc.2000.1163
Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c- jun N-terminal kinase activity FREE
B Liu, M Fang, M Schmidt, Y Lu, J Mendelsohn and Z Fan
Br J Cancer 82: 1991-1999; doi:10.1054/bjoc.2000.1201
Prostaglandin E2 and the protein kinase A pathway mediate arachidonic acid induction of c-fos in human prostate cancer cells FREE
Y Chen and M Hughes-Fulford
Br J Cancer 82: 2000-2006; doi:10.1054/bjoc.2000.1143
Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels FREE
S P Robinson, F A Howe, M Stubbs and J R Griffiths
Br J Cancer 82: 2007-2014; doi:10.1054/bjoc.2000.1144
Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 in cutaneous melanoma FREE
J M Karjalainen, J K Kellokoski, A J Mannermaa, H E Kujala, K I Moisio, P J Mitchell, M J Eskelinen, E M Alhava and V M Kosma
Br J Cancer 82: 2015-2021; doi:10.1054/bjoc.2000.1145
Letters to the Editor
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy FREE
J Shamash, R T D Oliver, C J Gallagher, A C Newland, T A Lister, S Kelsey, R K Gupta and C A O'Doherty
Br J Cancer 82: 2022-2023; doi:10.1054/bjoc.1999.1140
A possible cause of testicular cancer FREE
W H James
Br J Cancer 82: 2023; doi:10.1054/bjoc.1999.1137
Author Index to Volume 82
Top of pageKeyword Index to Volume 82
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
